Translocator Protein PET/CT in Various TSPO-Related Disease
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY
To evaluate the potential usefulness of 18F-DPA714/FDPA positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various TSPO-related disease patients.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: t
View:
• \- (i) adult patients (aged 18 years or order); (ii) patients with suspected or new diagnosed or previously treated malignant tumors (supporting evidence may include MRI, CT, tumor markers and pathology report); (iii) patients who had scheduled TSPO PET/CT scan; (iv) patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee.
Locations
Other Locations
China
The First Affiliated Hospital of University of Science and Technology of China
RECRUITING
Hefei
Tianjin Medical University General Hospital
RECRUITING
Tianjin
Contact Information
Primary
Ying Wang
macrossplusvoices@163.com
+8618702292537
Backup
Li Cai, MD
xcl242004@126.com
+862260362190
Time Frame
Start Date: 2018-11-01
Estimated Completion Date: 2027-12-01
Participants
Target number of participants: 200
Treatments
Single Group Assignment
Each subject receive a single intravenous injection of 18F-DPA714/FDPA, and undergo PET/CT or MRI imaging within the specificed time.
Related Therapeutic Areas
Sponsors
Leads: Tianjin Medical University
Collaborators: Tianjin Medical University General Hospital